Healthleap raises $38M for its AI that flags hospital patients who may need a closer look
$38M. Healthleap just closed funding for its hospital AI that flags high-risk patients — and it's already deployed.
Why it matters
Healthcare AI traction moves from research to clinical deployment. Healthleap's $38M raise (Sequoia, First Round, Hummingbird) signals investor confidence in clinical-risk flagging as a defensible, regulatory-navigable category — distinct from diagnostic models and closer to the operational/workflow layer hospitals already buy.
The key facts
8 to know$38M total raise: $8M seed (Sequoia, First Round co-led) + $30M Series A (Hummingbird Ventures)
Use case: patient risk flagging/triage — not diagnosis, reducing downstream clinical decisions
Deployment in hospital workflows implied by framing (not pilot-only language)
Timing: Oct 2026 — healthcare AI funding cycle remains robust despite broader market volatility
$38M total raise: $8M seed (co-led Sequoia Capital, First Round Capital) + $30M Series A (led Hummingbird Ventures)
Use case: AI flags hospitalized patients requiring closer clinical observation
Investors include tier-one VCs with healthcare track records (Sequoia, First Round, Hummingbird)
No deployment scale, reimbursement model, or customer count disclosed
Go to the source
TechCrunch AItechcrunch.com
Publisher excerpt: The financing includes an $8M seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures.